Israel released real-world research data of COVID-19 booster shot
- Oral probiotics can enhance the effects of immunotherapy
- Genetic study reveals why one Scottish woman can’t feel pain and her wounds heal faster
- About 80 lawsuits: Merck HPV vaccine is accused of concealing serious side effects!
- Can shingles virus vaccine reduce the incidence of Alzheimer’s disease?
- HMPV is raging across the United States and the death rate is as high as 43%!
- Alzheimer’s disease: Astrocyte reactivity is a key link in Aβ-driven tau pathology
Israel released real-world research data of COVID-19 booster shot
- Hmpv is raging across the United States and the death rate is as high as 43%!
- COVID “Arcturus” XBB.1.16: The first death in U.S.
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- How long can the patient live after heart stent surgery?
Israel released real-world research data of COVID-19 booster shot.
On October 29, 2021, the Clalit Research Institute of Israel and the Ministry of Health published a blockbuster study on Lancet, reporting the real-world protection of more than 720,000 people inoculated with the third dose of BNT162b2.
The study evaluated the protective power of 7 days after the third dose of 728,321 and compared it with people who received only two doses of 728,321, all of whom received the second dose for more than 5 months.
Prevent an infection
The study showed that compared with subjects who received only 2 doses of vaccine, the third dose group had 88% protection against asymptomatic infections and 91% protection against symptomatic infections.
Prevention of severe illness and death
Compared with subjects who completed only 2 doses of vaccination, BNT162b2 booster vaccination had a 93% protection against hospitalization, 92% protection against critical illness, and 81% protection against death.
Real-world research in Israel shows that compared with standard vaccination, booster shots can significantly reduce the risk of infection, serious illness, and death.
The situation has changed in the United Kingdom, which has been slow to use booster needles, the United States, which partially uses booster needles, and Israel, which has fully used booster needles. As shown in 👇:
(Changes in new cases in the United Kingdom, the United States, and Israel)
As a global testing center for COVID-19, Israel took the unknown risk to overcome the obstacles of the global anti-epidemic countermeasures. The result is that the case fatality rate (0.61%) is much lower than that of the United Kingdom (1.56%) and the United States (1.62%).
This real-world protection data, together with Pfizer’s phase 3 clinical trial protection data, can be used as complete data on the effectiveness of the third dose of vaccination.
Reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext
(source:internet, reference only)
Disclaimer of medicaltrend.org